1. Wang, Shengnan, Iyer, Radhika, Han, Xiaohua, Sun, Zhaolin, Fang, Deyu. 2023. CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion. In The Journal of clinical investigation, 133, . doi:10.1172/JCI167728. https://pubmed.ncbi.nlm.nih.gov/38038129/
2. Wu, Longxiang, Ou, Zhenyu, Liu, Peihua, Wang, Yongjie, Tang, Jianing. 2023. ATXN3 promotes prostate cancer progression by stabilizing YAP. In Cell communication and signaling : CCS, 21, 152. doi:10.1186/s12964-023-01073-9. https://pubmed.ncbi.nlm.nih.gov/37349820/
3. Wang, Shengnan, Liu, Kun, Han, Xiaohua, Sun, Zhaolin, Fang, Deyu. 2023. ATXN3 deubiquitinates YAP1 to promote tumor growth. In American journal of cancer research, 13, 4222-4234. doi:. https://pubmed.ncbi.nlm.nih.gov/37818078/
4. Zou, Haojing, Chen, Hongyan, Zhou, Zhuan, Wan, Yong, Liu, Zhihua. 2019. ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4. In Cancer letters, 467, 19-28. doi:10.1016/j.canlet.2019.09.012. https://pubmed.ncbi.nlm.nih.gov/31563563/
5. Paulson, Henry. . Machado-Joseph disease/spinocerebellar ataxia type 3. In Handbook of clinical neurology, 103, 437-49. doi:10.1016/B978-0-444-51892-7.00027-9. https://pubmed.ncbi.nlm.nih.gov/21827905/
6. Wu, Xin, Zhang, Xin, Liu, Peng, Wang, Yao. 2023. Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6. In Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 23, 630-641. doi:10.1016/j.pan.2023.06.011. https://pubmed.ncbi.nlm.nih.gov/37460341/
智鼠故事 
